TCM Biotech International Corp.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by TCM Biotech International Corp.
RECRUITINGPhase 1 / Phase 2NCT03812874
A Study of PTX-9908 Injection for Non-resectable HCC with TACE
This is a multicenter, Phase I/II study in patients with non-resectable hepatocellular carcinoma following TACE treatment. Phase I (Open-label dose escalation) This study will...
Sponsor: TCM Biotech International Corp.Enrolling: 501 location
Carcinoma, Hepatocellular
RECRUITINGNCT05930093
Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects
Non-alcoholic fatty liver disease (also called NAFLD) is a disease in which excessive fat accumulates in the liver of a patient without a history of alcohol abuse. Early-stage...
Sponsor: TCM Biotech International Corp.Enrolling: 1081 location
NAFLD
RECRUITINGPhase 3NCT07184827
Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women
The goal of this clinical trial is to learn if drug U101 works to prevent recurrent urinary tract infection (rUTI) in women (≥ 20 and \< 76 years old) with a medical history. It...
Sponsor: TCM Biotech International Corp.Enrolling: 34813 locations
Recurrent Urinary Tract Infections in Women